nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—ABCC3—lung cancer	0.159	0.392	CbGaD
Ezetimibe—UGT1A1—lung cancer	0.137	0.339	CbGaD
Ezetimibe—ABCG2—lung cancer	0.0771	0.19	CbGaD
Ezetimibe—ABCB1—lung cancer	0.0321	0.0792	CbGaD
Ezetimibe—ABCG2—Topotecan—lung cancer	0.0191	0.0492	CbGbCtD
Ezetimibe—UGT1A1—Erlotinib—lung cancer	0.0188	0.0484	CbGbCtD
Ezetimibe—ABCC3—Cisplatin—lung cancer	0.0186	0.0477	CbGbCtD
Ezetimibe—ABCC3—Etoposide—lung cancer	0.0182	0.0469	CbGbCtD
Ezetimibe—ABCG2—Gefitinib—lung cancer	0.0175	0.045	CbGbCtD
Ezetimibe—UGT1A1—Irinotecan—lung cancer	0.017	0.0437	CbGbCtD
Ezetimibe—ABCG2—Teniposide—lung cancer	0.017	0.0437	CbGbCtD
Ezetimibe—UGT1A1—Etoposide—lung cancer	0.0136	0.035	CbGbCtD
Ezetimibe—ABCC3—Doxorubicin—lung cancer	0.0124	0.032	CbGbCtD
Ezetimibe—ABCC3—Methotrexate—lung cancer	0.012	0.031	CbGbCtD
Ezetimibe—SLCO1B1—Irinotecan—lung cancer	0.0118	0.0303	CbGbCtD
Ezetimibe—ABCC2—Paclitaxel—lung cancer	0.0105	0.027	CbGbCtD
Ezetimibe—ABCG2—Erlotinib—lung cancer	0.0104	0.0266	CbGbCtD
Ezetimibe—ABCC2—Irinotecan—lung cancer	0.0103	0.0266	CbGbCtD
Ezetimibe—ABCG2—Paclitaxel—lung cancer	0.00948	0.0244	CbGbCtD
Ezetimibe—ABCG2—Irinotecan—lung cancer	0.00935	0.024	CbGbCtD
Ezetimibe—ABCC2—Vinblastine—lung cancer	0.00919	0.0236	CbGbCtD
Ezetimibe—ABCC2—Cisplatin—lung cancer	0.00843	0.0217	CbGbCtD
Ezetimibe—ABCC2—Etoposide—lung cancer	0.00828	0.0213	CbGbCtD
Ezetimibe—ABCG2—Cisplatin—lung cancer	0.00762	0.0196	CbGbCtD
Ezetimibe—ABCC2—Docetaxel—lung cancer	0.00758	0.0195	CbGbCtD
Ezetimibe—ABCG2—Etoposide—lung cancer	0.00749	0.0193	CbGbCtD
Ezetimibe—ABCB1—Topotecan—lung cancer	0.0069	0.0178	CbGbCtD
Ezetimibe—ABCG2—Docetaxel—lung cancer	0.00685	0.0176	CbGbCtD
Ezetimibe—ABCB1—Gefitinib—lung cancer	0.00631	0.0162	CbGbCtD
Ezetimibe—SLCO1B1—Methotrexate—lung cancer	0.00623	0.016	CbGbCtD
Ezetimibe—ABCC2—Doxorubicin—lung cancer	0.00565	0.0145	CbGbCtD
Ezetimibe—ABCC2—Methotrexate—lung cancer	0.00547	0.0141	CbGbCtD
Ezetimibe—ABCG2—Doxorubicin—lung cancer	0.00511	0.0131	CbGbCtD
Ezetimibe—ABCG2—Methotrexate—lung cancer	0.00495	0.0127	CbGbCtD
Ezetimibe—ABCB1—Vinorelbine—lung cancer	0.00486	0.0125	CbGbCtD
Ezetimibe—CYP3A4—Topotecan—lung cancer	0.00414	0.0106	CbGbCtD
Ezetimibe—ABCB1—Crizotinib—lung cancer	0.00387	0.00995	CbGbCtD
Ezetimibe—CYP3A4—Gefitinib—lung cancer	0.00378	0.00973	CbGbCtD
Ezetimibe—ABCB1—Gemcitabine—lung cancer	0.00378	0.00973	CbGbCtD
Ezetimibe—ABCB1—Erlotinib—lung cancer	0.00373	0.0096	CbGbCtD
Ezetimibe—CYP3A4—Teniposide—lung cancer	0.00367	0.00943	CbGbCtD
Ezetimibe—ABCB1—Paclitaxel—lung cancer	0.00342	0.00879	CbGbCtD
Ezetimibe—ABCB1—Irinotecan—lung cancer	0.00337	0.00867	CbGbCtD
Ezetimibe—ABCB1—Vinblastine—lung cancer	0.003	0.00771	CbGbCtD
Ezetimibe—CYP3A4—Vinorelbine—lung cancer	0.00291	0.00749	CbGbCtD
Ezetimibe—ABCB1—Cisplatin—lung cancer	0.00275	0.00707	CbGbCtD
Ezetimibe—ABCB1—Etoposide—lung cancer	0.0027	0.00694	CbGbCtD
Ezetimibe—ABCB1—Docetaxel—lung cancer	0.00247	0.00635	CbGbCtD
Ezetimibe—CYP3A4—Crizotinib—lung cancer	0.00232	0.00596	CbGbCtD
Ezetimibe—CYP3A4—Erlotinib—lung cancer	0.00224	0.00575	CbGbCtD
Ezetimibe—UGT2B15—mammary gland—lung cancer	0.00207	0.125	CbGeAlD
Ezetimibe—CYP3A4—Paclitaxel—lung cancer	0.00205	0.00526	CbGbCtD
Ezetimibe—CYP3A4—Irinotecan—lung cancer	0.00202	0.00519	CbGbCtD
Ezetimibe—ABCB1—Doxorubicin—lung cancer	0.00184	0.00474	CbGbCtD
Ezetimibe—CYP3A4—Vinblastine—lung cancer	0.0018	0.00462	CbGbCtD
Ezetimibe—ABCB1—Methotrexate—lung cancer	0.00178	0.00459	CbGbCtD
Ezetimibe—ANPEP—mammary gland—lung cancer	0.0017	0.103	CbGeAlD
Ezetimibe—CYP3A4—Etoposide—lung cancer	0.00162	0.00416	CbGbCtD
Ezetimibe—CYP3A4—Docetaxel—lung cancer	0.00148	0.00381	CbGbCtD
Ezetimibe—SOAT1—respiratory system—lung cancer	0.00118	0.0719	CbGeAlD
Ezetimibe—ANPEP—respiratory system—lung cancer	0.00113	0.0688	CbGeAlD
Ezetimibe—CYP3A4—Doxorubicin—lung cancer	0.0011	0.00284	CbGbCtD
Ezetimibe—SOAT1—bronchus—lung cancer	0.000974	0.0592	CbGeAlD
Ezetimibe—ANPEP—epithelium—lung cancer	0.000946	0.0575	CbGeAlD
Ezetimibe—ANPEP—bronchus—lung cancer	0.000932	0.0566	CbGeAlD
Ezetimibe—SLCO1B1—mammary gland—lung cancer	0.000893	0.0542	CbGeAlD
Ezetimibe—ANPEP—trachea—lung cancer	0.000837	0.0508	CbGeAlD
Ezetimibe—SOAT1—bone marrow—lung cancer	0.000694	0.0421	CbGeAlD
Ezetimibe—ANPEP—bone marrow—lung cancer	0.000664	0.0403	CbGeAlD
Ezetimibe—SOAT1—lung—lung cancer	0.000629	0.0382	CbGeAlD
Ezetimibe—ANPEP—lung—lung cancer	0.000601	0.0365	CbGeAlD
Ezetimibe—ABCC3—respiratory system—lung cancer	0.000564	0.0343	CbGeAlD
Ezetimibe—SOAT1—lymph node—lung cancer	0.00043	0.0261	CbGeAlD
Ezetimibe—ANPEP—lymph node—lung cancer	0.000411	0.025	CbGeAlD
Ezetimibe—Flunarizine—CYP2A6—lung cancer	0.000366	0.371	CrCbGaD
Ezetimibe—ABCC3—lung—lung cancer	0.0003	0.0182	CbGeAlD
Ezetimibe—Flunarizine—CYP1A1—lung cancer	0.000256	0.26	CrCbGaD
Ezetimibe—Pimozide—CYP2E1—lung cancer	0.000239	0.243	CrCbGaD
Ezetimibe—ABCC3—lymph node—lung cancer	0.000205	0.0124	CbGeAlD
Ezetimibe—ABCG2—bone marrow—lung cancer	0.000193	0.0117	CbGeAlD
Ezetimibe—ABCG2—lung—lung cancer	0.000175	0.0106	CbGeAlD
Ezetimibe—ABCC2—lymph node—lung cancer	0.000164	0.00995	CbGeAlD
Ezetimibe—ABCB1—respiratory system—lung cancer	0.000162	0.00985	CbGeAlD
Ezetimibe—ABCB1—epithelium—lung cancer	0.000136	0.00823	CbGeAlD
Ezetimibe—Pimozide—ABCB1—lung cancer	0.000126	0.127	CrCbGaD
Ezetimibe—ABCB1—trachea—lung cancer	0.00012	0.00728	CbGeAlD
Ezetimibe—ABCG2—lymph node—lung cancer	0.000119	0.00725	CbGeAlD
Ezetimibe—ABCB1—bone marrow—lung cancer	9.5e-05	0.00577	CbGeAlD
Ezetimibe—ABCB1—lung—lung cancer	8.61e-05	0.00523	CbGeAlD
Ezetimibe—Body temperature increased—Irinotecan—lung cancer	6.04e-05	0.00062	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Doxorubicin—lung cancer	6.04e-05	0.00062	CcSEcCtD
Ezetimibe—Decreased appetite—Cisplatin—lung cancer	6.03e-05	0.000619	CcSEcCtD
Ezetimibe—Nasopharyngitis—Doxorubicin—lung cancer	6e-05	0.000616	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Cisplatin—lung cancer	5.99e-05	0.000615	CcSEcCtD
Ezetimibe—Anaemia—Docetaxel—lung cancer	5.99e-05	0.000614	CcSEcCtD
Ezetimibe—Infestation—Methotrexate—lung cancer	5.97e-05	0.000613	CcSEcCtD
Ezetimibe—Infestation NOS—Methotrexate—lung cancer	5.97e-05	0.000613	CcSEcCtD
Ezetimibe—Gastritis—Doxorubicin—lung cancer	5.94e-05	0.000609	CcSEcCtD
Ezetimibe—Pain—Cisplatin—lung cancer	5.94e-05	0.000609	CcSEcCtD
Ezetimibe—Muscular weakness—Doxorubicin—lung cancer	5.92e-05	0.000607	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Doxorubicin—lung cancer	5.92e-05	0.000607	CcSEcCtD
Ezetimibe—Vomiting—Vinorelbine—lung cancer	5.89e-05	0.000605	CcSEcCtD
Ezetimibe—ABCB1—lymph node—lung cancer	5.89e-05	0.00358	CbGeAlD
Ezetimibe—Body temperature increased—Gemcitabine—lung cancer	5.89e-05	0.000604	CcSEcCtD
Ezetimibe—Rash—Vinorelbine—lung cancer	5.84e-05	0.0006	CcSEcCtD
Ezetimibe—Dermatitis—Vinorelbine—lung cancer	5.84e-05	0.000599	CcSEcCtD
Ezetimibe—Headache—Vinorelbine—lung cancer	5.81e-05	0.000596	CcSEcCtD
Ezetimibe—Influenza—Doxorubicin—lung cancer	5.8e-05	0.000595	CcSEcCtD
Ezetimibe—Eosinophilia—Doxorubicin—lung cancer	5.74e-05	0.000589	CcSEcCtD
Ezetimibe—Palpitations—Docetaxel—lung cancer	5.72e-05	0.000587	CcSEcCtD
Ezetimibe—Feeling abnormal—Cisplatin—lung cancer	5.72e-05	0.000587	CcSEcCtD
Ezetimibe—Paraesthesia—Etoposide—lung cancer	5.71e-05	0.000586	CcSEcCtD
Ezetimibe—Pancreatitis—Doxorubicin—lung cancer	5.69e-05	0.000583	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Paclitaxel—lung cancer	5.68e-05	0.000583	CcSEcCtD
Ezetimibe—Dyspnoea—Etoposide—lung cancer	5.67e-05	0.000582	CcSEcCtD
Ezetimibe—Cough—Docetaxel—lung cancer	5.65e-05	0.00058	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Methotrexate—lung cancer	5.65e-05	0.000579	CcSEcCtD
Ezetimibe—Insomnia—Paclitaxel—lung cancer	5.64e-05	0.000579	CcSEcCtD
Ezetimibe—Hypersensitivity—Irinotecan—lung cancer	5.63e-05	0.000578	CcSEcCtD
Ezetimibe—Paraesthesia—Paclitaxel—lung cancer	5.6e-05	0.000574	CcSEcCtD
Ezetimibe—Hypertension—Docetaxel—lung cancer	5.59e-05	0.000574	CcSEcCtD
Ezetimibe—Dyspnoea—Paclitaxel—lung cancer	5.56e-05	0.00057	CcSEcCtD
Ezetimibe—Decreased appetite—Etoposide—lung cancer	5.53e-05	0.000567	CcSEcCtD
Ezetimibe—Myalgia—Docetaxel—lung cancer	5.51e-05	0.000566	CcSEcCtD
Ezetimibe—Chest pain—Docetaxel—lung cancer	5.51e-05	0.000566	CcSEcCtD
Ezetimibe—Arthralgia—Docetaxel—lung cancer	5.51e-05	0.000566	CcSEcCtD
Ezetimibe—Nausea—Vinorelbine—lung cancer	5.51e-05	0.000565	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Etoposide—lung cancer	5.49e-05	0.000563	CcSEcCtD
Ezetimibe—Dyspepsia—Paclitaxel—lung cancer	5.49e-05	0.000563	CcSEcCtD
Ezetimibe—Body temperature increased—Cisplatin—lung cancer	5.49e-05	0.000563	CcSEcCtD
Ezetimibe—Asthenia—Irinotecan—lung cancer	5.49e-05	0.000563	CcSEcCtD
Ezetimibe—Fatigue—Etoposide—lung cancer	5.48e-05	0.000562	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	5.48e-05	0.000562	CcSEcCtD
Ezetimibe—Pain—Etoposide—lung cancer	5.44e-05	0.000558	CcSEcCtD
Ezetimibe—Constipation—Etoposide—lung cancer	5.44e-05	0.000558	CcSEcCtD
Ezetimibe—Decreased appetite—Paclitaxel—lung cancer	5.42e-05	0.000556	CcSEcCtD
Ezetimibe—Dry mouth—Docetaxel—lung cancer	5.39e-05	0.000553	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Doxorubicin—lung cancer	5.39e-05	0.000553	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Paclitaxel—lung cancer	5.38e-05	0.000552	CcSEcCtD
Ezetimibe—Fatigue—Paclitaxel—lung cancer	5.38e-05	0.000551	CcSEcCtD
Ezetimibe—Hepatitis—Methotrexate—lung cancer	5.36e-05	0.00055	CcSEcCtD
Ezetimibe—Asthenia—Gemcitabine—lung cancer	5.34e-05	0.000548	CcSEcCtD
Ezetimibe—Pain—Paclitaxel—lung cancer	5.33e-05	0.000547	CcSEcCtD
Ezetimibe—Constipation—Paclitaxel—lung cancer	5.33e-05	0.000547	CcSEcCtD
Ezetimibe—Confusional state—Docetaxel—lung cancer	5.33e-05	0.000547	CcSEcCtD
Ezetimibe—Pharyngitis—Methotrexate—lung cancer	5.32e-05	0.000546	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Doxorubicin—lung cancer	5.29e-05	0.000543	CcSEcCtD
Ezetimibe—Anaphylactic shock—Docetaxel—lung cancer	5.28e-05	0.000542	CcSEcCtD
Ezetimibe—Pruritus—Gemcitabine—lung cancer	5.27e-05	0.000541	CcSEcCtD
Ezetimibe—Infection—Docetaxel—lung cancer	5.25e-05	0.000539	CcSEcCtD
Ezetimibe—Feeling abnormal—Etoposide—lung cancer	5.24e-05	0.000538	CcSEcCtD
Ezetimibe—Diarrhoea—Irinotecan—lung cancer	5.23e-05	0.000537	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Etoposide—lung cancer	5.2e-05	0.000533	CcSEcCtD
Ezetimibe—Nervous system disorder—Docetaxel—lung cancer	5.18e-05	0.000532	CcSEcCtD
Ezetimibe—Thrombocytopenia—Docetaxel—lung cancer	5.17e-05	0.000531	CcSEcCtD
Ezetimibe—Infestation—Doxorubicin—lung cancer	5.17e-05	0.000531	CcSEcCtD
Ezetimibe—Infestation NOS—Doxorubicin—lung cancer	5.17e-05	0.000531	CcSEcCtD
Ezetimibe—Feeling abnormal—Paclitaxel—lung cancer	5.14e-05	0.000527	CcSEcCtD
Ezetimibe—Skin disorder—Docetaxel—lung cancer	5.13e-05	0.000527	CcSEcCtD
Ezetimibe—Hypersensitivity—Cisplatin—lung cancer	5.11e-05	0.000525	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Paclitaxel—lung cancer	5.1e-05	0.000523	CcSEcCtD
Ezetimibe—Diarrhoea—Gemcitabine—lung cancer	5.1e-05	0.000523	CcSEcCtD
Ezetimibe—Erythema multiforme—Methotrexate—lung cancer	5.07e-05	0.00052	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Doxorubicin—lung cancer	5.07e-05	0.00052	CcSEcCtD
Ezetimibe—Dizziness—Irinotecan—lung cancer	5.06e-05	0.000519	CcSEcCtD
Ezetimibe—Urticaria—Etoposide—lung cancer	5.05e-05	0.000518	CcSEcCtD
Ezetimibe—Jaundice—Doxorubicin—lung cancer	5.04e-05	0.000517	CcSEcCtD
Ezetimibe—Body temperature increased—Etoposide—lung cancer	5.03e-05	0.000516	CcSEcCtD
Ezetimibe—Abdominal pain—Etoposide—lung cancer	5.03e-05	0.000516	CcSEcCtD
Ezetimibe—Asthenia—Cisplatin—lung cancer	4.98e-05	0.000511	CcSEcCtD
Ezetimibe—Urticaria—Paclitaxel—lung cancer	4.95e-05	0.000508	CcSEcCtD
Ezetimibe—Abdominal pain—Paclitaxel—lung cancer	4.93e-05	0.000506	CcSEcCtD
Ezetimibe—Body temperature increased—Paclitaxel—lung cancer	4.93e-05	0.000506	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Doxorubicin—lung cancer	4.89e-05	0.000502	CcSEcCtD
Ezetimibe—Angiopathy—Methotrexate—lung cancer	4.86e-05	0.000499	CcSEcCtD
Ezetimibe—Vomiting—Irinotecan—lung cancer	4.86e-05	0.000499	CcSEcCtD
Ezetimibe—Sinusitis—Doxorubicin—lung cancer	4.85e-05	0.000498	CcSEcCtD
Ezetimibe—Immune system disorder—Methotrexate—lung cancer	4.84e-05	0.000497	CcSEcCtD
Ezetimibe—Mediastinal disorder—Methotrexate—lung cancer	4.83e-05	0.000496	CcSEcCtD
Ezetimibe—Rash—Irinotecan—lung cancer	4.82e-05	0.000495	CcSEcCtD
Ezetimibe—Dermatitis—Irinotecan—lung cancer	4.82e-05	0.000494	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Docetaxel—lung cancer	4.82e-05	0.000494	CcSEcCtD
Ezetimibe—Headache—Irinotecan—lung cancer	4.79e-05	0.000491	CcSEcCtD
Ezetimibe—Insomnia—Docetaxel—lung cancer	4.78e-05	0.00049	CcSEcCtD
Ezetimibe—Diarrhoea—Cisplatin—lung cancer	4.75e-05	0.000487	CcSEcCtD
Ezetimibe—Paraesthesia—Docetaxel—lung cancer	4.75e-05	0.000487	CcSEcCtD
Ezetimibe—Alopecia—Methotrexate—lung cancer	4.74e-05	0.000486	CcSEcCtD
Ezetimibe—Vomiting—Gemcitabine—lung cancer	4.74e-05	0.000486	CcSEcCtD
Ezetimibe—Dyspnoea—Docetaxel—lung cancer	4.71e-05	0.000483	CcSEcCtD
Ezetimibe—Mental disorder—Methotrexate—lung cancer	4.7e-05	0.000482	CcSEcCtD
Ezetimibe—Rash—Gemcitabine—lung cancer	4.7e-05	0.000482	CcSEcCtD
Ezetimibe—Dermatitis—Gemcitabine—lung cancer	4.69e-05	0.000481	CcSEcCtD
Ezetimibe—Hypersensitivity—Etoposide—lung cancer	4.69e-05	0.000481	CcSEcCtD
Ezetimibe—Erythema—Methotrexate—lung cancer	4.67e-05	0.000479	CcSEcCtD
Ezetimibe—Malnutrition—Methotrexate—lung cancer	4.67e-05	0.000479	CcSEcCtD
Ezetimibe—Headache—Gemcitabine—lung cancer	4.67e-05	0.000479	CcSEcCtD
Ezetimibe—Dyspepsia—Docetaxel—lung cancer	4.65e-05	0.000477	CcSEcCtD
Ezetimibe—Hepatitis—Doxorubicin—lung cancer	4.64e-05	0.000476	CcSEcCtD
Ezetimibe—Pharyngitis—Doxorubicin—lung cancer	4.61e-05	0.000473	CcSEcCtD
Ezetimibe—Decreased appetite—Docetaxel—lung cancer	4.59e-05	0.000471	CcSEcCtD
Ezetimibe—Hypersensitivity—Paclitaxel—lung cancer	4.59e-05	0.000471	CcSEcCtD
Ezetimibe—Oedema peripheral—Doxorubicin—lung cancer	4.57e-05	0.000469	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Docetaxel—lung cancer	4.56e-05	0.000468	CcSEcCtD
Ezetimibe—Asthenia—Etoposide—lung cancer	4.56e-05	0.000468	CcSEcCtD
Ezetimibe—Connective tissue disorder—Doxorubicin—lung cancer	4.56e-05	0.000468	CcSEcCtD
Ezetimibe—Fatigue—Docetaxel—lung cancer	4.56e-05	0.000467	CcSEcCtD
Ezetimibe—Nausea—Irinotecan—lung cancer	4.54e-05	0.000466	CcSEcCtD
Ezetimibe—Pain—Docetaxel—lung cancer	4.52e-05	0.000464	CcSEcCtD
Ezetimibe—Constipation—Docetaxel—lung cancer	4.52e-05	0.000464	CcSEcCtD
Ezetimibe—Back pain—Methotrexate—lung cancer	4.51e-05	0.000463	CcSEcCtD
Ezetimibe—Pruritus—Etoposide—lung cancer	4.5e-05	0.000462	CcSEcCtD
Ezetimibe—Asthenia—Paclitaxel—lung cancer	4.47e-05	0.000459	CcSEcCtD
Ezetimibe—Nausea—Gemcitabine—lung cancer	4.42e-05	0.000454	CcSEcCtD
Ezetimibe—Vomiting—Cisplatin—lung cancer	4.41e-05	0.000453	CcSEcCtD
Ezetimibe—Pruritus—Paclitaxel—lung cancer	4.41e-05	0.000453	CcSEcCtD
Ezetimibe—Erythema multiforme—Doxorubicin—lung cancer	4.39e-05	0.00045	CcSEcCtD
Ezetimibe—Rash—Cisplatin—lung cancer	4.38e-05	0.000449	CcSEcCtD
Ezetimibe—Dermatitis—Cisplatin—lung cancer	4.37e-05	0.000449	CcSEcCtD
Ezetimibe—Feeling abnormal—Docetaxel—lung cancer	4.36e-05	0.000447	CcSEcCtD
Ezetimibe—Diarrhoea—Etoposide—lung cancer	4.35e-05	0.000446	CcSEcCtD
Ezetimibe—Ill-defined disorder—Methotrexate—lung cancer	4.33e-05	0.000444	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Docetaxel—lung cancer	4.32e-05	0.000443	CcSEcCtD
Ezetimibe—Anaemia—Methotrexate—lung cancer	4.31e-05	0.000443	CcSEcCtD
Ezetimibe—Flushing—Doxorubicin—lung cancer	4.31e-05	0.000442	CcSEcCtD
Ezetimibe—Diarrhoea—Paclitaxel—lung cancer	4.27e-05	0.000438	CcSEcCtD
Ezetimibe—Angiopathy—Doxorubicin—lung cancer	4.21e-05	0.000432	CcSEcCtD
Ezetimibe—Malaise—Methotrexate—lung cancer	4.21e-05	0.000432	CcSEcCtD
Ezetimibe—Dizziness—Etoposide—lung cancer	4.21e-05	0.000431	CcSEcCtD
Ezetimibe—Immune system disorder—Doxorubicin—lung cancer	4.19e-05	0.00043	CcSEcCtD
Ezetimibe—Mediastinal disorder—Doxorubicin—lung cancer	4.18e-05	0.000429	CcSEcCtD
Ezetimibe—Abdominal pain—Docetaxel—lung cancer	4.18e-05	0.000429	CcSEcCtD
Ezetimibe—Body temperature increased—Docetaxel—lung cancer	4.18e-05	0.000429	CcSEcCtD
Ezetimibe—Dizziness—Paclitaxel—lung cancer	4.12e-05	0.000423	CcSEcCtD
Ezetimibe—Nausea—Cisplatin—lung cancer	4.12e-05	0.000423	CcSEcCtD
Ezetimibe—Alopecia—Doxorubicin—lung cancer	4.1e-05	0.000421	CcSEcCtD
Ezetimibe—Cough—Methotrexate—lung cancer	4.07e-05	0.000418	CcSEcCtD
Ezetimibe—Mental disorder—Doxorubicin—lung cancer	4.07e-05	0.000417	CcSEcCtD
Ezetimibe—Vomiting—Etoposide—lung cancer	4.04e-05	0.000415	CcSEcCtD
Ezetimibe—Erythema—Doxorubicin—lung cancer	4.04e-05	0.000415	CcSEcCtD
Ezetimibe—Malnutrition—Doxorubicin—lung cancer	4.04e-05	0.000415	CcSEcCtD
Ezetimibe—Rash—Etoposide—lung cancer	4.01e-05	0.000411	CcSEcCtD
Ezetimibe—Dermatitis—Etoposide—lung cancer	4.01e-05	0.000411	CcSEcCtD
Ezetimibe—Headache—Etoposide—lung cancer	3.98e-05	0.000409	CcSEcCtD
Ezetimibe—Flatulence—Doxorubicin—lung cancer	3.98e-05	0.000409	CcSEcCtD
Ezetimibe—Myalgia—Methotrexate—lung cancer	3.97e-05	0.000408	CcSEcCtD
Ezetimibe—Arthralgia—Methotrexate—lung cancer	3.97e-05	0.000408	CcSEcCtD
Ezetimibe—Chest pain—Methotrexate—lung cancer	3.97e-05	0.000408	CcSEcCtD
Ezetimibe—Vomiting—Paclitaxel—lung cancer	3.96e-05	0.000407	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.95e-05	0.000405	CcSEcCtD
Ezetimibe—Rash—Paclitaxel—lung cancer	3.93e-05	0.000403	CcSEcCtD
Ezetimibe—Dermatitis—Paclitaxel—lung cancer	3.93e-05	0.000403	CcSEcCtD
Ezetimibe—Discomfort—Methotrexate—lung cancer	3.93e-05	0.000403	CcSEcCtD
Ezetimibe—Back pain—Doxorubicin—lung cancer	3.91e-05	0.000401	CcSEcCtD
Ezetimibe—Headache—Paclitaxel—lung cancer	3.91e-05	0.000401	CcSEcCtD
Ezetimibe—Hypersensitivity—Docetaxel—lung cancer	3.89e-05	0.000399	CcSEcCtD
Ezetimibe—Muscle spasms—Doxorubicin—lung cancer	3.89e-05	0.000399	CcSEcCtD
Ezetimibe—Confusional state—Methotrexate—lung cancer	3.84e-05	0.000394	CcSEcCtD
Ezetimibe—Anaphylactic shock—Methotrexate—lung cancer	3.81e-05	0.000391	CcSEcCtD
Ezetimibe—Asthenia—Docetaxel—lung cancer	3.79e-05	0.000389	CcSEcCtD
Ezetimibe—Infection—Methotrexate—lung cancer	3.78e-05	0.000388	CcSEcCtD
Ezetimibe—Nausea—Etoposide—lung cancer	3.78e-05	0.000388	CcSEcCtD
Ezetimibe—Ill-defined disorder—Doxorubicin—lung cancer	3.75e-05	0.000385	CcSEcCtD
Ezetimibe—Pruritus—Docetaxel—lung cancer	3.74e-05	0.000384	CcSEcCtD
Ezetimibe—Nervous system disorder—Methotrexate—lung cancer	3.74e-05	0.000383	CcSEcCtD
Ezetimibe—Anaemia—Doxorubicin—lung cancer	3.74e-05	0.000383	CcSEcCtD
Ezetimibe—Thrombocytopenia—Methotrexate—lung cancer	3.73e-05	0.000383	CcSEcCtD
Ezetimibe—Nausea—Paclitaxel—lung cancer	3.7e-05	0.00038	CcSEcCtD
Ezetimibe—Skin disorder—Methotrexate—lung cancer	3.7e-05	0.00038	CcSEcCtD
Ezetimibe—Malaise—Doxorubicin—lung cancer	3.64e-05	0.000374	CcSEcCtD
Ezetimibe—Diarrhoea—Docetaxel—lung cancer	3.62e-05	0.000371	CcSEcCtD
Ezetimibe—Palpitations—Doxorubicin—lung cancer	3.57e-05	0.000366	CcSEcCtD
Ezetimibe—Cough—Doxorubicin—lung cancer	3.53e-05	0.000362	CcSEcCtD
Ezetimibe—Dizziness—Docetaxel—lung cancer	3.49e-05	0.000359	CcSEcCtD
Ezetimibe—Hypertension—Doxorubicin—lung cancer	3.49e-05	0.000358	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Methotrexate—lung cancer	3.47e-05	0.000356	CcSEcCtD
Ezetimibe—Insomnia—Methotrexate—lung cancer	3.45e-05	0.000353	CcSEcCtD
Ezetimibe—Myalgia—Doxorubicin—lung cancer	3.44e-05	0.000353	CcSEcCtD
Ezetimibe—Chest pain—Doxorubicin—lung cancer	3.44e-05	0.000353	CcSEcCtD
Ezetimibe—Arthralgia—Doxorubicin—lung cancer	3.44e-05	0.000353	CcSEcCtD
Ezetimibe—Paraesthesia—Methotrexate—lung cancer	3.42e-05	0.000351	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.42e-05	0.000351	CcSEcCtD
Ezetimibe—Discomfort—Doxorubicin—lung cancer	3.4e-05	0.000349	CcSEcCtD
Ezetimibe—Dyspnoea—Methotrexate—lung cancer	3.4e-05	0.000348	CcSEcCtD
Ezetimibe—Dry mouth—Doxorubicin—lung cancer	3.36e-05	0.000345	CcSEcCtD
Ezetimibe—Vomiting—Docetaxel—lung cancer	3.36e-05	0.000345	CcSEcCtD
Ezetimibe—Dyspepsia—Methotrexate—lung cancer	3.35e-05	0.000344	CcSEcCtD
Ezetimibe—Rash—Docetaxel—lung cancer	3.33e-05	0.000342	CcSEcCtD
Ezetimibe—Dermatitis—Docetaxel—lung cancer	3.33e-05	0.000342	CcSEcCtD
Ezetimibe—Confusional state—Doxorubicin—lung cancer	3.33e-05	0.000341	CcSEcCtD
Ezetimibe—Decreased appetite—Methotrexate—lung cancer	3.31e-05	0.00034	CcSEcCtD
Ezetimibe—Headache—Docetaxel—lung cancer	3.31e-05	0.00034	CcSEcCtD
Ezetimibe—Anaphylactic shock—Doxorubicin—lung cancer	3.3e-05	0.000338	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Methotrexate—lung cancer	3.29e-05	0.000337	CcSEcCtD
Ezetimibe—Fatigue—Methotrexate—lung cancer	3.28e-05	0.000337	CcSEcCtD
Ezetimibe—Infection—Doxorubicin—lung cancer	3.28e-05	0.000336	CcSEcCtD
Ezetimibe—Pain—Methotrexate—lung cancer	3.26e-05	0.000334	CcSEcCtD
Ezetimibe—Nervous system disorder—Doxorubicin—lung cancer	3.23e-05	0.000332	CcSEcCtD
Ezetimibe—Thrombocytopenia—Doxorubicin—lung cancer	3.23e-05	0.000331	CcSEcCtD
Ezetimibe—Skin disorder—Doxorubicin—lung cancer	3.2e-05	0.000329	CcSEcCtD
Ezetimibe—Nausea—Docetaxel—lung cancer	3.14e-05	0.000322	CcSEcCtD
Ezetimibe—Feeling abnormal—Methotrexate—lung cancer	3.14e-05	0.000322	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Methotrexate—lung cancer	3.11e-05	0.00032	CcSEcCtD
Ezetimibe—Urticaria—Methotrexate—lung cancer	3.03e-05	0.00031	CcSEcCtD
Ezetimibe—Body temperature increased—Methotrexate—lung cancer	3.01e-05	0.000309	CcSEcCtD
Ezetimibe—Abdominal pain—Methotrexate—lung cancer	3.01e-05	0.000309	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.01e-05	0.000308	CcSEcCtD
Ezetimibe—Insomnia—Doxorubicin—lung cancer	2.98e-05	0.000306	CcSEcCtD
Ezetimibe—Paraesthesia—Doxorubicin—lung cancer	2.96e-05	0.000304	CcSEcCtD
Ezetimibe—Dyspnoea—Doxorubicin—lung cancer	2.94e-05	0.000302	CcSEcCtD
Ezetimibe—Dyspepsia—Doxorubicin—lung cancer	2.9e-05	0.000298	CcSEcCtD
Ezetimibe—Decreased appetite—Doxorubicin—lung cancer	2.87e-05	0.000294	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Doxorubicin—lung cancer	2.85e-05	0.000292	CcSEcCtD
Ezetimibe—Fatigue—Doxorubicin—lung cancer	2.84e-05	0.000292	CcSEcCtD
Ezetimibe—Pain—Doxorubicin—lung cancer	2.82e-05	0.000289	CcSEcCtD
Ezetimibe—Constipation—Doxorubicin—lung cancer	2.82e-05	0.000289	CcSEcCtD
Ezetimibe—Hypersensitivity—Methotrexate—lung cancer	2.81e-05	0.000288	CcSEcCtD
Ezetimibe—Asthenia—Methotrexate—lung cancer	2.73e-05	0.00028	CcSEcCtD
Ezetimibe—Feeling abnormal—Doxorubicin—lung cancer	2.72e-05	0.000279	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Doxorubicin—lung cancer	2.7e-05	0.000277	CcSEcCtD
Ezetimibe—Pruritus—Methotrexate—lung cancer	2.69e-05	0.000276	CcSEcCtD
Ezetimibe—Urticaria—Doxorubicin—lung cancer	2.62e-05	0.000269	CcSEcCtD
Ezetimibe—Abdominal pain—Doxorubicin—lung cancer	2.61e-05	0.000267	CcSEcCtD
Ezetimibe—Body temperature increased—Doxorubicin—lung cancer	2.61e-05	0.000267	CcSEcCtD
Ezetimibe—Diarrhoea—Methotrexate—lung cancer	2.61e-05	0.000267	CcSEcCtD
Ezetimibe—Dizziness—Methotrexate—lung cancer	2.52e-05	0.000258	CcSEcCtD
Ezetimibe—Hypersensitivity—Doxorubicin—lung cancer	2.43e-05	0.000249	CcSEcCtD
Ezetimibe—Vomiting—Methotrexate—lung cancer	2.42e-05	0.000248	CcSEcCtD
Ezetimibe—Rash—Methotrexate—lung cancer	2.4e-05	0.000246	CcSEcCtD
Ezetimibe—Dermatitis—Methotrexate—lung cancer	2.4e-05	0.000246	CcSEcCtD
Ezetimibe—Headache—Methotrexate—lung cancer	2.39e-05	0.000245	CcSEcCtD
Ezetimibe—Asthenia—Doxorubicin—lung cancer	2.37e-05	0.000243	CcSEcCtD
Ezetimibe—Pruritus—Doxorubicin—lung cancer	2.33e-05	0.000239	CcSEcCtD
Ezetimibe—Nausea—Methotrexate—lung cancer	2.26e-05	0.000232	CcSEcCtD
Ezetimibe—Diarrhoea—Doxorubicin—lung cancer	2.26e-05	0.000232	CcSEcCtD
Ezetimibe—Dizziness—Doxorubicin—lung cancer	2.18e-05	0.000224	CcSEcCtD
Ezetimibe—Vomiting—Doxorubicin—lung cancer	2.1e-05	0.000215	CcSEcCtD
Ezetimibe—Rash—Doxorubicin—lung cancer	2.08e-05	0.000213	CcSEcCtD
Ezetimibe—Dermatitis—Doxorubicin—lung cancer	2.08e-05	0.000213	CcSEcCtD
Ezetimibe—Headache—Doxorubicin—lung cancer	2.07e-05	0.000212	CcSEcCtD
Ezetimibe—Nausea—Doxorubicin—lung cancer	1.96e-05	0.000201	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—AKT1—lung cancer	5.2e-06	5.7e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NQO1—lung cancer	5.18e-06	5.68e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CAT—lung cancer	5.18e-06	5.67e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CAT—lung cancer	5.18e-06	5.67e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.15e-06	5.64e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	5.13e-06	5.62e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PGAM1—lung cancer	5.1e-06	5.59e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ABCB1—lung cancer	5.04e-06	5.52e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ABCB1—lung cancer	5.04e-06	5.52e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—EP300—lung cancer	5.03e-06	5.52e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ALB—lung cancer	5.01e-06	5.49e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	4.99e-06	5.47e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	4.98e-06	5.46e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ENO1—lung cancer	4.96e-06	5.43e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—CREBBP—lung cancer	4.95e-06	5.43e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—TYMS—lung cancer	4.95e-06	5.42e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—TYMS—lung cancer	4.95e-06	5.42e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSTM1—lung cancer	4.89e-06	5.36e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSTM1—lung cancer	4.89e-06	5.36e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2A7—lung cancer	4.87e-06	5.34e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	4.83e-06	5.29e-05	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—RAF1—lung cancer	4.82e-06	5.28e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	4.82e-06	5.28e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP2E1—lung cancer	4.8e-06	5.26e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—SDC4—lung cancer	4.76e-06	5.22e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NQO1—lung cancer	4.75e-06	5.2e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—APOA1—lung cancer	4.68e-06	5.12e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—STK11—lung cancer	4.67e-06	5.12e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ATP5H—lung cancer	4.66e-06	5.1e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.65e-06	5.1e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—POMC—lung cancer	4.64e-06	5.09e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ALB—lung cancer	4.64e-06	5.08e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP1A1—lung cancer	4.63e-06	5.08e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP1A1—lung cancer	4.63e-06	5.08e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.61e-06	5.05e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ERCC2—lung cancer	4.6e-06	5.04e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ERCC2—lung cancer	4.6e-06	5.04e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	4.6e-06	5.04e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—RAF1—lung cancer	4.53e-06	4.96e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	4.47e-06	4.9e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP2E1—lung cancer	4.45e-06	4.87e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NQO1—lung cancer	4.4e-06	4.82e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	4.35e-06	4.77e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—RRM1—lung cancer	4.34e-06	4.76e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTA3—lung cancer	4.34e-06	4.76e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTP1—lung cancer	4.32e-06	4.74e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—STK11—lung cancer	4.28e-06	4.69e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CG—lung cancer	4.27e-06	4.68e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CAT—lung cancer	4.21e-06	4.61e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—RAF1—lung cancer	4.19e-06	4.6e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PLBD1—lung cancer	4.15e-06	4.55e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	4.14e-06	4.54e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	4.12e-06	4.51e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ABCB1—lung cancer	4.09e-06	4.48e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—B4GALT5—lung cancer	4.08e-06	4.47e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—POMC—lung cancer	4.06e-06	4.45e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—TYMS—lung cancer	4.02e-06	4.4e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.02e-06	4.4e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	4e-06	4.39e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APOA1—lung cancer	3.98e-06	4.36e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APOA1—lung cancer	3.98e-06	4.36e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTM1—lung cancer	3.97e-06	4.35e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTA4—lung cancer	3.97e-06	4.35e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—STK11—lung cancer	3.96e-06	4.34e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTP1—lung cancer	3.96e-06	4.34e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CREBBP—lung cancer	3.96e-06	4.34e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	3.92e-06	4.29e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTA2—lung cancer	3.87e-06	4.24e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CAT—lung cancer	3.86e-06	4.22e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.83e-06	4.2e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.81e-06	4.17e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HSD17B10—lung cancer	3.8e-06	4.16e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP1A1—lung cancer	3.77e-06	4.13e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CD—lung cancer	3.75e-06	4.11e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ABCB1—lung cancer	3.75e-06	4.11e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ERCC2—lung cancer	3.74e-06	4.09e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTA1—lung cancer	3.73e-06	4.09e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PIK3CA—lung cancer	3.72e-06	4.08e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ALB—lung cancer	3.71e-06	4.06e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	3.7e-06	4.05e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ABCC3—lung cancer	3.69e-06	4.04e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—TYMS—lung cancer	3.68e-06	4.04e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTP1—lung cancer	3.67e-06	4.02e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTM1—lung cancer	3.64e-06	3.99e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CG—lung cancer	3.63e-06	3.98e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CG—lung cancer	3.63e-06	3.98e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKR1C1—lung cancer	3.57e-06	3.92e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CAT—lung cancer	3.57e-06	3.91e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CKB—lung cancer	3.53e-06	3.87e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ABCB1—lung cancer	3.47e-06	3.8e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—UGT1A1—lung cancer	3.47e-06	3.8e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—POMC—lung cancer	3.46e-06	3.79e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—POMC—lung cancer	3.46e-06	3.79e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP1A1—lung cancer	3.45e-06	3.78e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ERCC2—lung cancer	3.42e-06	3.75e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—TYMS—lung cancer	3.41e-06	3.74e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	3.4e-06	3.72e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTM1—lung cancer	3.37e-06	3.69e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CREBBP—lung cancer	3.37e-06	3.69e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CREBBP—lung cancer	3.37e-06	3.69e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GNG11—lung cancer	3.35e-06	3.67e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CNDP2—lung cancer	3.32e-06	3.63e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTM2—lung cancer	3.32e-06	3.63e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	3.29e-06	3.6e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CB—lung cancer	3.27e-06	3.58e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—lung cancer	3.24e-06	3.55e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—APOA1—lung cancer	3.23e-06	3.54e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MTMR3—lung cancer	3.23e-06	3.54e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP1A1—lung cancer	3.2e-06	3.5e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CD—lung cancer	3.19e-06	3.5e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CD—lung cancer	3.19e-06	3.5e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALDOA—lung cancer	3.19e-06	3.49e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ERCC2—lung cancer	3.17e-06	3.47e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	3.16e-06	3.47e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ALB—lung cancer	3.15e-06	3.45e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ALB—lung cancer	3.15e-06	3.45e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PGAM1—lung cancer	3.14e-06	3.45e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NCOA3—lung cancer	3.09e-06	3.39e-05	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—AKT1—lung cancer	3.04e-06	3.33e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ADCY1—lung cancer	3.01e-06	3.3e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ABCG2—lung cancer	3.01e-06	3.3e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2A7—lung cancer	3e-06	3.29e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APOA1—lung cancer	2.96e-06	3.24e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CG—lung cancer	2.95e-06	3.23e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HPGDS—lung cancer	2.95e-06	3.23e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ENO2—lung cancer	2.95e-06	3.23e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—SDC4—lung cancer	2.94e-06	3.22e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PPP2R1B—lung cancer	2.93e-06	3.21e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTT1—lung cancer	2.86e-06	3.14e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.84e-06	3.11e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GCLC—lung cancer	2.83e-06	3.1e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2A6—lung cancer	2.83e-06	3.1e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTEN—lung cancer	2.83e-06	3.1e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—POMC—lung cancer	2.81e-06	3.08e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CB—lung cancer	2.78e-06	3.05e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CB—lung cancer	2.78e-06	3.05e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.78e-06	3.04e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—lung cancer	2.76e-06	3.02e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—lung cancer	2.76e-06	3.02e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APOA1—lung cancer	2.74e-06	3e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CREBBP—lung cancer	2.74e-06	3e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CG—lung cancer	2.7e-06	2.96e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—EP300—lung cancer	2.7e-06	2.95e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ENO1—lung cancer	2.68e-06	2.94e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	2.68e-06	2.94e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—RRM1—lung cancer	2.67e-06	2.93e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTA3—lung cancer	2.67e-06	2.93e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CD—lung cancer	2.59e-06	2.84e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—POMC—lung cancer	2.57e-06	2.82e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ALB—lung cancer	2.56e-06	2.81e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—B4GALT5—lung cancer	2.51e-06	2.75e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	2.51e-06	2.75e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CREBBP—lung cancer	2.51e-06	2.75e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CG—lung cancer	2.5e-06	2.74e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTA4—lung cancer	2.45e-06	2.68e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP2E1—lung cancer	2.4e-06	2.64e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTEN—lung cancer	2.4e-06	2.63e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTEN—lung cancer	2.4e-06	2.63e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTA2—lung cancer	2.38e-06	2.61e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—POMC—lung cancer	2.38e-06	2.61e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NQO1—lung cancer	2.38e-06	2.61e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CD—lung cancer	2.38e-06	2.6e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ALB—lung cancer	2.35e-06	2.57e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CREBBP—lung cancer	2.32e-06	2.54e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTA1—lung cancer	2.3e-06	2.52e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—EP300—lung cancer	2.29e-06	2.51e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—EP300—lung cancer	2.29e-06	2.51e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCC3—lung cancer	2.27e-06	2.49e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	2.27e-06	2.48e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CB—lung cancer	2.26e-06	2.48e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—lung cancer	2.24e-06	2.45e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKR1C1—lung cancer	2.2e-06	2.41e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CD—lung cancer	2.2e-06	2.41e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ALB—lung cancer	2.17e-06	2.38e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—STK11—lung cancer	2.14e-06	2.35e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—UGT1A1—lung cancer	2.14e-06	2.34e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CB—lung cancer	2.07e-06	2.27e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GNG11—lung cancer	2.06e-06	2.26e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—lung cancer	2.05e-06	2.25e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PIK3CA—lung cancer	1.99e-06	2.19e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTP1—lung cancer	1.98e-06	2.17e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALDOA—lung cancer	1.96e-06	2.15e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTEN—lung cancer	1.95e-06	2.14e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CAT—lung cancer	1.93e-06	2.11e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CB—lung cancer	1.92e-06	2.1e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NCOA3—lung cancer	1.91e-06	2.09e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—lung cancer	1.9e-06	2.08e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—EP300—lung cancer	1.86e-06	2.04e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ADCY1—lung cancer	1.85e-06	2.03e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCG2—lung cancer	1.85e-06	2.03e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—TYMS—lung cancer	1.84e-06	2.02e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTM1—lung cancer	1.82e-06	2e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ENO2—lung cancer	1.82e-06	1.99e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HPGDS—lung cancer	1.82e-06	1.99e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.81e-06	1.98e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTEN—lung cancer	1.79e-06	1.96e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTT1—lung cancer	1.76e-06	1.93e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GCLC—lung cancer	1.74e-06	1.91e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2A6—lung cancer	1.74e-06	1.91e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP1A1—lung cancer	1.73e-06	1.89e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ERCC2—lung cancer	1.71e-06	1.88e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—EP300—lung cancer	1.71e-06	1.87e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PIK3CA—lung cancer	1.7e-06	1.86e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PIK3CA—lung cancer	1.7e-06	1.86e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTEN—lung cancer	1.66e-06	1.82e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ENO1—lung cancer	1.65e-06	1.81e-05	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—AKT1—lung cancer	1.63e-06	1.79e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—EP300—lung cancer	1.58e-06	1.73e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APOA1—lung cancer	1.48e-06	1.62e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP2E1—lung cancer	1.48e-06	1.62e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NQO1—lung cancer	1.47e-06	1.61e-05	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—AKT1—lung cancer	1.39e-06	1.52e-05	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—AKT1—lung cancer	1.39e-06	1.52e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PIK3CA—lung cancer	1.38e-06	1.51e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CG—lung cancer	1.35e-06	1.48e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—STK11—lung cancer	1.32e-06	1.45e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—POMC—lung cancer	1.29e-06	1.41e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PIK3CA—lung cancer	1.26e-06	1.38e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CREBBP—lung cancer	1.25e-06	1.37e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTP1—lung cancer	1.22e-06	1.34e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CD—lung cancer	1.19e-06	1.3e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CAT—lung cancer	1.19e-06	1.3e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALB—lung cancer	1.17e-06	1.29e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PIK3CA—lung cancer	1.17e-06	1.28e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ABCB1—lung cancer	1.16e-06	1.27e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—TYMS—lung cancer	1.14e-06	1.24e-05	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—AKT1—lung cancer	1.13e-06	1.23e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTM1—lung cancer	1.12e-06	1.23e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP1A1—lung cancer	1.06e-06	1.17e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ERCC2—lung cancer	1.06e-06	1.16e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CB—lung cancer	1.04e-06	1.14e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—AKT1—lung cancer	1.03e-06	1.13e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—lung cancer	1.03e-06	1.13e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—AKT1—lung cancer	9.55e-07	1.05e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APOA1—lung cancer	9.13e-07	1e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTEN—lung cancer	8.96e-07	9.82e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—EP300—lung cancer	8.55e-07	9.36e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CG—lung cancer	8.34e-07	9.14e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—POMC—lung cancer	7.94e-07	8.7e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CREBBP—lung cancer	7.73e-07	8.47e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CD—lung cancer	7.33e-07	8.03e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALB—lung cancer	7.24e-07	7.93e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CB—lung cancer	6.39e-07	7e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—lung cancer	6.33e-07	6.94e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PIK3CA—lung cancer	6.32e-07	6.93e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTEN—lung cancer	5.52e-07	6.05e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—EP300—lung cancer	5.26e-07	5.77e-06	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—AKT1—lung cancer	5.16e-07	5.66e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PIK3CA—lung cancer	3.89e-07	4.27e-06	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—AKT1—lung cancer	3.18e-07	3.49e-06	CbGpPWpGaD
